As part of UCSF’s Spring 2019 RAP funding cycle, CTSI is offering a new pilot award (up to $40,000) to support research projects focused on the prevention and treatment of opioid disorders.
The Pilot Award for the Prevention and Treatment of Opioid Use Disorders aligns with the research priorities identified in the NIH HEAL Initiative addressing the opioid crisis through translational science.
Project applications in any aspect of clinical research will be considered. Examples include:
- Implementation strategies for evidence-based approaches in multiple settings including primary and emergency care, the criminal justice system, and other community settings, and in communities highly affected by the opioid crisis;
- Populations that may be at-risk which include older adolescents and young adults (ages 16-30) which is a group at highest risk for opioid initiation, misuse, OUD and overdose fatality; individuals born with Neonatal Abstinence Syndrome (NAS)/Neonatal Opioid Withdrawal Syndrome (NOWS); homeless populations; and those with co-occurring health conditions including other substance-abuse disorders, mood and anxiety disorders
- Evidence-based approaches that can be integrated or embedded into health care systems.
CTSI offers a wide range of additional funds through RAP for the Spring 2019 cycle including the Pilot for Junior Investigators in Basic and Clinical/Translational Sciences, Family Support Award and Under-Represented Faculty & Senior Fellows in Clinical and Translational Research Awards.
View all CTSI funding opportunities (Application deadline March 11, 2019)